CVS Health Q1 Earnings Surpass Expectations with Aetna Driving Growth

CVS Health surpassed first-quarter expectations for both earnings and revenue, strengthening its outlook for 2026. The improved performance is primarily driven by its US insurance division, Aetna, enabling CVS to project a full-year profit of $7.30 to $7.50 per share, up from initial forecasts of $7 to $7.20.

The company has revised its 2026 revenue outlook to at least $405 billion, an increase from the earlier estimate of $400 billion. CFO Brian Newman emphasized to CNBC that all major segments, including insurance, retail pharmacy, and health services, exceeded market revenue expectations.

Aetna's standout performance occurs amidst rising medical expenses affecting major insurers. CVS's comprehensive approach includes cost reductions, strategic store closures, leadership restructuring, and optimizing Medicare Advantage plan expenses. "From an investor lens, we aimed for pragmatic targets and have pursued avenues to surpass them," Newman remarked.

Following these announcements, CVS shares climbed over 4% in premarket trading. In the first quarter, CVS reported $2.94 billion in net income or $2.30 per share, up from $1.78 billion or $1.41 per share the previous year. Adjusted earnings, excluding specific items, reached $2.57 per share. Revenue was reported at $100.43 billion, a 6.2% year-over-year increase, with positive contributions from each business segment.

The insurance sector generated $35.97 billion in revenue, marking a 3% increase from the prior year's first quarter and surpassing the analyst forecast of $33.28 billion. Newman credited Aetna's operational improvements for enhanced efficiency amid ongoing medical cost challenges. The medical benefit ratio improved to 84.6% from 87.3%, indicating greater profitability.

Additionally, CVS resolved earlier financial reserves for premium shortfalls, supporting profitability. Sales in the pharmacy and consumer wellness division were stable at $31.99 billion, slightly exceeding analyst forecasts. The health services segment, including pharmacy benefits manager Caremark, experienced an 11% revenue boost to $48.24 billion.

Overall, CVS's robust performance signals a promising horizon for the health insurance sector. Future quarters will further clarify ongoing medical cost trends and their implications for the broader market.